Ted Roth

Ted Roth

Board of Directors

Ted Roth has over 30 years of investment and management experience in a range of industries from venture technology to established natural resource and industrial companies. Ted is currently COO and CFO of Radicle Science, a healthcare data analytics company and Chairman of Systems Mobile Inc., a content and media SaaS company with operations throughout Latin America. Previously, Ted was managing partner of Totem Investment Partners, a venture fund focused on early-stage technology investments and active public market investing. Ted has been an active investor and board member for over 25 companies ranging from digital transformation technologies, media, manufacturing, real estate, and medical devices. Portfolio companies have included Captiva (IPO, acquired by EMC/Dell), Marcom Central (acquired by Ricoh), CD Radio (now Sirius/XM), Electrocom Automation (IPO, acquired by Siemens), and Inetcam (private sale).

Previously, Ted, was CEO of Totem Enterprises, Inc., a management company for a family office with diversified international holdings and CFO of Minera Yolanda, a Chilean minerals start-up company. He was instrumental in the public/private financing structuring, IPO and sale of that company to Nutrien. Ted holds an accounting degree from the University of Illinois and a JD from Marquette University. Ted has been an active advisor and board member with numerous non-profit organizations, including the San Diego Chamber Orchestra, Old Globe Theatre, United Way, Special Olympics and Rancho Santa Fe Community Center.

Scott Thorogood

Scott Thorogood

Chairman and Co-founder

William Freeman

William Freeman, MD

Medical Advisor and Co-founder

Larry Murril

Larry Murrill

CFO

Partnership logos

In partnership with the University of California, San Diego.

Ready to learn more?

Our technology is singularly unique in how the sub retinal device tailors the electrical neural stimulation parameters to the individual patient. It is the most advanced technology available capable of achieving such a degree of patient specificity.

Contact Us